Business
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
Hi, what are you looking for?
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
Mylan offered Perrigo shareholders $75 plus 2.3 Mylan shares per Perrigo share, for a total of $35.6 billion. Perrigo Company (NYSE:PRGO; TASE:PRGO) board of...
Mylan, itself the subject of a hostile takeover bid from Teva, is raising its offer for Perrigo for the second time. Mylan N.V. has...
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.
Israel’s Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver...
Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a...
– The company will use the offering to help finance the $4.5 billion acquisition of Omega Pharma. OTC pharmaceutical company Perrigo Company (NYSE:PRGO; TASE:PRGO)...
Sol-Gel is trying to improve acne and rosacea treatments using nanoscale particles. Businessman Mori Arkin is in advanced talks to buy Sol-Gel, which...